Loading insider details...
Beta
Latest Form 4 (May 29, 2026): Grant/Award of 26,000 ANRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 26,000 | n/a |
| Mar 4, 2026 | Kyverna Therapeutics, Inc. (KYTX) | Grant/Award | 11,006 | n/a |
| Mar 18, 2024 | Karuna Therapeutics, Inc. (KRTX) | Disposition to Issuer | 13,977 | $4.61M |
| Feb 15, 2024 | Karuna Therapeutics, Inc. (KRTX) | Grant/Award | 15,855 | n/a |
| Feb 12, 2024 | Karuna Therapeutics, Inc. (KRTX) | Tax Withholding | 1,011 | $320.6K |